Atypical chemokine receptor 3 (ACKR3) Antibody (FITC)

Este producto es parte de CXCR - C-X-C motif chemokine receptor
Product Graph
325€ (100 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Atypical chemokine receptor 3 (ACKR3) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx347382
tested applications
FCM

Description

Atypical chemokine receptor 3 (ACKR3) Antibody (FITC) is a FITC-conjugated Mouse Monoclonal antibody for Atypical chemokine receptor 3 (ACKR3).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Atypical chemokine receptor 3 (ACKR3)
Host
Mouse
Reactivity
Human
Recommended Dilution
FCM: 4 µl/100 µl whole blood or 106 cells. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
FITC
Clone ID
C252
Purification
Purified by size-exclusion chromatography.
Size 1
100 tests
Form
Liquid
Tested Applications
FCM
Buffer
PBS, pH 7.4, 15 mM sodium azide.
Availability
Shipped within 5-12 working days.
Storage
Store at 2-8°C in the dark. Do not freeze.
Dry Ice
No
UniProt ID
P25106
Gene ID
57007
Alias
chemokine (C-X-C motif) receptor 7,chemokine orphan receptor 1,CXCR7,Cxcr7,GPR159 ,G-protein coupled receptor 159,RDC-1,RDC1,CMKOR16
Background
Antibody anti-ACKR3
Status
RUO

Descripción

Related Products

FNab02104

ACKR3 antibody

Ver Producto
FNab02105

ACKR3 antibody

CXCR7, also named as CMKOR1, GPR159 and RDC1, belongs to the G-protein coupled receptor 1 family. It is a receptor for CXCL12/SDF1. CXCR7 acts as coreceptor with CXCR4 for a restricted number of HIV isolates. CXCR7 was shown to contribute to neoangiogenesis in prostate cancer and to promote tumor cell proliferation in breast cancer and adenocarcinoma of the lung.

Ver Producto
FNab02106

ACKR3 antibody

Ver Producto